A number of stocks witnessed heightened trading activity on June 3 as corporate announcements and regulatory developments drove investor sentiment.

John Cockerill India shares gained after the company announced a new order win, reinforcing its strong order pipeline and growth outlook. The engineering company has been securing contracts from leading steel manufacturers, strengthening its position in the industrial equipment segment. Investor optimism around the company's expanding order book supported the stock's upward movement.

Bliss GVS Pharma hit a fresh 52-week high after reports indicated the successful closure of a regulatory inspection, easing compliance-related concerns and improving investor confidence. The development was viewed positively by the market, given the importance of regulatory clearances for pharmaceutical manufacturers.

Advait Energy Transitions also remained in focus following recent business developments and continued investor interest in companies linked to the energy transition and power infrastructure segments. The stock witnessed active trading as market participants assessed its growth prospects.

Meanwhile, Concord Biotech attracted attention after recent corporate updates and strong market performance. The biotechnology company has been among the notable gainers in recent sessions, supported by positive sentiment toward the healthcare and pharmaceutical sectors.

The movement in these stocks highlights how company-specific developments, including order wins, regulatory outcomes, and business expansion initiatives, continue to influence investor sentiment despite broader market trends.